October 2024 PFAS Legislative Developments

October Legislation Tracking (October 1 – October 31)

Current Trends in Legislation – October 2024

Federal Legislature

    • No new bills were introduced.

Federal Regulations

  • There were no federal regulations of note in October.

State Legislature

  • Two bills were introduced.

State Regulations

  • There were no significant developments in state regulations.

New Bills This Period

PFAS Legislation

Federal

  • No new bills introduced.

    State

      • Two (2) bills introduced.
      • Two (2) in NJ.

      Signed into Law

      No bills were passed into law related to PFAS in October 2024.

        Highlighted Bills – PFAS Legislation

        Federal
        State
        State Bill: SR 116 (NJ)
        • Bill Name: A bill for the Federal Government to offer legal remedy 
        • Sponsors: Vin Gopal
        • Introduced: 10/28/2024
        • Status: Referred to Senate Environment and Energy Committee
        • Summary: The bill requests the federal government to offer legal remedies to victims exposed to PFAS and incentivize research into effects of these substances. The bill aims to catalyze Congressional action to indemnify PFAS harms. The bill states that the fragmented state-level response to PFAS exposure necessitates a unified federal cause of action.
        State Bill: S 3783 (NJ)
        • Bill Name: AN ACT prohibiting the use of artificial turf 
        • Sponsors: Raj Mukherji
        • Introduced: 10/10/2024
        • Status: Referred to Senate Environment and Energy Committee
        • Summary: The bill prohibits the purchase, installation, or use of artificial turf by a municipality, school district, or State department or agency for a new or existing field. The bill specifically cites the risks associated with the presence of PFAS in artificial turf.

        Updates on Previously Highlighted Bills

        Federal
        State
        HB1153 (MD) was approved by the Governor 5/9/2024. This bill establishes limits for PFAS in any water discharged by industrial entities.
        S25 (VT) was approved by the Governor 5/30/2024. This bill prohibits the sale of certain products, including cosmetics, mistral products, and textiles containing intentionally-added PFAS.

        John Gardella

        Shareholder

        PFAS, Environmental, Litigation

        John Gardella and his team were recognized by National Law Review as the only Thought Leader in the nation in 2020 on the subject of PFAS. Attorney Gardella regularly consults with corporate, insurance, and financial world clients to assess risks in a multitude of transaction types. While he has specialized his practice for the past five years on the subject of PFAS, he has fifteen years of litigation and environmental practice that shapes the expertise that he offers to his clients to predict future risks. His opinions are sought out by media, such as Bloomberg, AM Best, and numerous industry-specific publications.

        Email John Gardella

        Amaran Toppa

        Director of Client Relations & Development

        Amaran Toppa joined CMBG3 Law in 2017 after almost three years in the investment management industry. In addition to her time in the financial sector, Mrs. Toppa has over 15 years of experience working with law firms who have litigated and consulted on ESG, Environmental, Insurance, Toxic Tort, Criminal and Civil matters. As a member of the CMBG3’s Government Affairs team, Mrs. Toppa analyzes and provides guidance on important policy and regulatory issues to the firm’s practice groups. She also assists with strategizing policy responses and develops relationships with key federal and state legislators and agency members to lobby on issues important to the firm’s clients.

        Email Amaran

        Tori Paiva

        Legislative Analyst

        Tori Paiva is a Legislative Analyst at CMBG3 Law specializing in ESG, PFAS, Environmental and Tort issues. Ms. Paiva has extensive knowledge and expertise pertaining to federal regulators bodies including OSHA, EPA, DEP, and the FDA. With her expertise on both federal and local regulations, she has helped with the national defense strategies for her clients and continues to inform our attorneys on pertinent issues developing in the regulatory realm. As a member of the Government Affairs team, she is responsible for monitoring and reporting on legislative priorities, and regularly attends congressional hearings. As a registered lobbyist, Ms. Paiva also meets with Federal and State stakeholders to advance priorities important to firm clients.

        Email Tori

        Speak to Your PFAS Legislative Experts



          Submit a Comment

          Your email address will not be published. Required fields are marked *

          ©2016 – 2024 CMBG3 Law, P.C. All rights reserved.